Dear Sir, Please find the attachment. Regards, For MRC Agrotech Limited Authorised Signatory / Compliance Officer
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board on June 5, 2025 approved two preferential share issuances at Rs. 19.50 per share: (1) about 21.98 lakh shares to raise Rs. 4.29 crore in cash from non-promoters and promoters, and (2) about 86.42 lakh shares worth around Rs. 16.85 crore to be issued as consideration for acquiring 100% of MARSAPI Lifesciences Private Limited through a share swap. MARSAPI Lifesciences operates in the pharma herbal industry with FY25 turnover of Rs. 95.50 lakhs, EBITDA of Rs. 6.68 lakhs, and holds 4 intellectual property rights. The authorised share capital will be raised from Rs. 20.5 crore to Rs. 35.5 crore to accommodate the new shares. An EGM is scheduled for June 28, 2025 to seek shareholder approval. The acquisition qualifies as a related party transaction because Chairman Ashok Kumar Singh is a director and shareholder in both companies, though the company states it is being done at arm's length.
Existing shareholders will see meaningful dilution from over 1 crore new shares being issued. The acquisition brings strategic diversification into pharma/herbal and agri-tech, but the related party nature of the deal and the small revenue base of the target (under Rs. 1 crore turnover) may draw investor scrutiny. Share price may react based on how the market views the acquisition value and the Rs. 9.50 premium over face value.